Encision Inc (ECIA) stock
Close on Oct 19, 2026Market cap $163.15KP/E –Yield –
Encision Inc saw revenue fall 3.0% to $6.30M over the twelve months to Sep 30, 2025. Free cash flow was -$544.87K, down 290.8% from a year earlier. At the latest close the market valued the company at $163.15K.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2025
Valuation
- Market cap
- $163.15K
- P/E ratio
- –
- Price to sales
- 0.03
- Price to book
- 0.09
- Dividend yield
- –
- Free cash flow yield
- -333.96%
Fundamentals
- Revenue
- $6.30M
- Net income
- -$380.94K
- EPS, diluted
- -$0.02
- Free cash flow
- -$544.87K
- Book value per share
- $0.13
- Diluted shares
- 14M
Trading
- Previous close
- $0.01
- Open
- $0.01
- Day's range
- $0.01 – $0.01
- Volume
- 0
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | ECIA | S&P 500 | Difference | ECIA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -71.7% | +0.6% | −72.3 pts | ||
| 3 months | -74.6% | +3.4% | −77.9 pts | ||
| Year to date | -91.8% | +13.3% | −105.1 pts | ||
| 1 year | -95.9% | +16.6% | −112.5 pts | ||
| 3 years | -97.5% | +86.4% | −183.9 pts | -70.8% | +23.1% |
| 5 years | -99.2% | +81.9% | −181.1 pts | -62.2% | +12.7% |
| 10 years | -96.7% | +318.9% | −415.6 pts | -28.9% | +15.4% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Encision filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- Results
- Results
- Results
- Results
About Encision
Surgical & Medical Instruments & Apparatus
Encision Inc. designs, manufactures, and markets medical devices specializing in surgical instruments for minimally invasive laparoscopic procedures. The company’s patented Active Electrode Monitoring technology prevents stray electrosurgical energy and accidental burn injuries from insulation failure or capacitive coupling. Its product portfolio features shielded and monitored endo-mechanical instruments, including surgical scissors, graspers, dissectors, fixed-tip electrodes, and suction-irrigation electrodes, available in reusable and disposable designs. Encision also provides monitor units and smart cords such as the EndoShield 2 burn protection system, along with proof-of-concept surgical robotic services. Its customers primarily include hospitals, surgeons, and healthcare networks.
Company profile, executives and historyEncision stock: common questions
What is Encision's stock price?
ECIA closed at $0.01 on Oct 19, 2026, up 0.00% on the day.
What is Encision's market cap?
Encision was worth $163.15K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is ECIA's P/E ratio?
Encision lost money over the twelve months to Sep 30, 2025 (diluted EPS -$0.02), so it has no meaningful P/E ratio.
How much revenue does Encision make?
Encision reported revenue of $6.30M for the twelve months to Sep 30, 2025, down 3.0% from a year earlier.
Does Encision pay a dividend?
No. Encision has not paid a cash dividend over the last twelve months.
How has ECIA stock performed over the past year?
Including dividends, ECIA returned -95.9% over the past year, against +16.6% for the S&P 500.
Who are Encision's competitors?
Companies most similar to Encision by business, industry and size include LUCD, NMTC, UTMD, MDNC, TNON.
See a number that looks wrong?